Services Home > New Guidelines for PCIs
 

New guidelines for percutaneous coronary intervention (PCI) have been issued jointly by the American Heart Association (AHA), the American College of Cardiology (ACC) and the Society for Cardiovascular Angiography and Interventions (SCAI). The updated document, released here at the AHA's Scientific Sessions 2005, replaces the previous PCI guidelines issued in 2001.

The announcement was made by the guidelines committee chairman, Dr. Sidney C. Smith, Jr. He said that one of the primary goals of the updated guidelines is to achieve a door-to-balloon time of 90 minutes or less for PCI in patients with occluded coronary arteries.

In the four years since the previous guidelines were issued, there have been a number of advances in technology and technique that change the setting of PCI. One of the most important of these is the development of drug-eluting stents, which are now almost universally used in stent placement, said Dr. Smith, of the University of North Carolina.

 

6 Key Changes

Six key areas have been identified and are now incorporated into the updated guidelines, Dr. Smith said. Drug-eluting stents is one, and the guidelines identify diabetics as a group that benefits in particular from stent placement.

Second, operator volume has been identified as pivotal in PCI outcome, with an annual operator volume of 75 procedures per year, including 11 emergent PCIs per year, as a critical cut-off number for best proficiency.

Third, the guidelines recommend that elective PCI be performed only at centers with cardiac surgery facilities onsite.

The guidelines identify the left main coronary artery as having particular significance, with PCI "reasonable to perform [on the left main] in patients not eligible for bypass surgery," Dr. Smith said.

A fifth highlight of the updated guidelines is the recommendation for distal protection with stent placement, which "dramatically improves the safety of stent procedures."

A sixth addition to the guidelines is a set of recommendations for patient care after PCI, and includes the use of platelet inhibition for at least a year and implementation of target levels of LDL cholesterol below 70 mg/dl. Dr. Smith said these new recommendations may be rapidly outdated with results of a major clinical study of post-PCI patient management anticipated for spring.

 

 

Call to Receive Medical Expert CVs and Discuss Your Case

 

Indox Consulting provides access to board certified physicians practicing in all specialties nationwide. Our medical professionals can review your case in a timely, cost effective fashion and support your case through trial with authoritative analysis, affidavits and compelling testimony.

Call us to discuss your case today.


Back to Top >
HOME ABOUT US SERVICES ARCHIVES FAQS CONTACT
Indox Consulting:
479 Church St. Suite 2
San Francisco, CA 94114
Phone: 1-415-568-7116
Email: info@indoxconsulting.com
©2005, Indox Consulting

Autopsies
Forensic DNA Testing
Life Care Plans
Independent Medical Exams (IMEs)
Toxicology

Treating Insomnia In the Primary Care Setting

• New Guidelines for PCIs

Cervical Cancer Screening: New Updates
Rheumatology and Pain Management
New PSA Guidelines & Protate Cancer